These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15735237)

  • 61. Chronic intermittent intravenous insulin therapy corrects orthostatic hypotension of diabetes.
    Aoki TT; Grecu EO; Arcangeli MA
    Am J Med; 1995 Dec; 99(6):683-4. PubMed ID: 7503093
    [No Abstract]   [Full Text] [Related]  

  • 62. Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray.
    Perry L; James S; Gallagher R; Dunbabin J; Steinbeck K; Lowe J
    J Eval Clin Pract; 2017 Aug; 23(4):719-724. PubMed ID: 28220558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Better diabetic control with a 4-dose regime--the insulin pen makes the change easier].
    Johannsson G; Stenström G; Fahl H; Andersson AG; Fors B
    Lakartidningen; 1991 Mar; 88(11):954, 957, 959-60. PubMed ID: 2008146
    [No Abstract]   [Full Text] [Related]  

  • 64. Management of Prolonged Aerobic Exercise in People With Type 1 Diabetes on Automated Insulin Delivery Systems: A Randomized Controlled Study.
    Corrado A; Scidà G; Abuqwider J; Rainone C; Lupoli R; Masulli M; Bozzetto L; Annuzzi G
    Diabetes Care; 2024 Oct; 47(10):e76-e77. PubMed ID: 39163549
    [No Abstract]   [Full Text] [Related]  

  • 65. A caution regarding U-500 insulin by continuous subcutaneous infusion.
    Goldberg LD
    Endocr Pract; 2004; 10(2):163, author reply 163. PubMed ID: 15256337
    [No Abstract]   [Full Text] [Related]  

  • 66. Improved quality of life in unselected insulin pump-treated children with type 1 diabetes in Eastern Nebraska.
    Rendell S; Kosoko-Lasaki O; Penny G; Cook CT; Sharma A; Austin WP; Rendell M
    J Diabetes Sci Technol; 2013 Mar; 7(2):579-81. PubMed ID: 23567015
    [No Abstract]   [Full Text] [Related]  

  • 67. Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose.
    Mauvais-Jarvis F; Sobngwi E; Porcher R; Garnier JP; Vexiau P; Duvallet A; Gautier JF
    Diabetes Care; 2003 Apr; 26(4):1316-7. PubMed ID: 12663620
    [No Abstract]   [Full Text] [Related]  

  • 68. Letter written in response to van bon et Al.: "Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial".
    Jovanovič L
    Diabetes Technol Ther; 2011 Aug; 13(8):869-70; author response 871. PubMed ID: 21732826
    [No Abstract]   [Full Text] [Related]  

  • 69. Automated Insulin Delivery: A Milestone on the Road to Insulin Independence in Type 1 Diabetes.
    Limbert C; Kowalski AJ; Danne TPA
    Diabetes Care; 2024 Jun; 47(6):918-920. PubMed ID: 38768333
    [No Abstract]   [Full Text] [Related]  

  • 70. A fresh look at continuous subcutaneous insulin infusion.
    Jones R; Mustafa N
    JAAPA; 2008 Mar; 21(3):36-7, 41-2. PubMed ID: 18432046
    [No Abstract]   [Full Text] [Related]  

  • 71. Routes of insulin administration: an issue or nonissue?
    Stephen RL
    J Diabet Complications; 1990; 4(3):95-7. PubMed ID: 2147437
    [No Abstract]   [Full Text] [Related]  

  • 72. Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry. Reply to Rigalleau et al.
    Grammes J; Küstner E; Dapp A; Hummel M; Kämmer JC; Kubiak T; Schütz-Fuhrmann I; Zimny S; Bollow E; Holl RW;
    Diabet Med; 2020 Jul; 37(7):1209-1210. PubMed ID: 32319106
    [No Abstract]   [Full Text] [Related]  

  • 73. [Not Available].
    Stief L
    MMW Fortschr Med; 2024 Oct; 166(16):19. PubMed ID: 39322880
    [No Abstract]   [Full Text] [Related]  

  • 74. Continuous subcutaneous insulin infusion: a local perspective.
    Yau TTL; Jenkins AJ; Ma RCW
    Hong Kong Med J; 2023 Aug; 29(4):337-341. PubMed ID: 37584226
    [No Abstract]   [Full Text] [Related]  

  • 75. Insulin treatment: a non-stop revolution.
    Mirouze J
    Diabetologia; 1983 Sep; 25(3):209-21. PubMed ID: 6357909
    [No Abstract]   [Full Text] [Related]  

  • 76. A new experience for incorrect insulin administration.
    Kirac CO; Ipekci SH; Kebapcilar L
    Acta Diabetol; 2018 Sep; 55(9):985-986. PubMed ID: 29934655
    [No Abstract]   [Full Text] [Related]  

  • 77. Ease of use of two reusable, half-unit increment dosing insulin pens by adult caregivers of children with type 1 diabetes: a randomized, crossover comparison.
    Wong M; Abdulnabi R; Fu H
    J Diabetes Sci Technol; 2013 Mar; 7(2):582-3. PubMed ID: 23567016
    [No Abstract]   [Full Text] [Related]  

  • 78. Diabetes: Once weekly insulin could be as effective as daily injections, studies indicate.
    Wise J
    BMJ; 2024 Sep; 386():q2005. PubMed ID: 39266233
    [No Abstract]   [Full Text] [Related]  

  • 79. Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations.
    Forlenza GP; Sherr JL
    Diabetes Technol Ther; 2024 Oct; 26(10):785-786. PubMed ID: 38512386
    [No Abstract]   [Full Text] [Related]  

  • 80. Regarding: Insulin Infusion Set Failures.
    Muchmore DB
    Diabetes Technol Ther; 2022 Aug; 24(8):599-600. PubMed ID: 35913844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.